The expansion of Butantan Biological Institute’s Covid-19 vaccine factory is on schedule: construction will start in November, São Paulo Governor João Doria announced on Monday. Mr. Doria also expressed that the project will cost around BRL 160 million, of which BRL 97 million (more than 60 percent) has already been raised in a state partnership with the private sector. However, the investment won’t be used for the creation of a new research facility, but to offer a new, modern structure to the existing institute, which is part of the University of São Paulo (USP).
The CoronaVac, a vaccine developed alongside the Chinese laboratory Sinovac Biotech, should be delivered in H2 2021. The new structure expected in the Butantan Institutecould produce up to 100 million doses of the medicine per year, including other types of vaccines for other future medical campaigns.
The director of the Institute, Dimas Covas, said the facility should be completed by the end of 2021, allowing the site to operate “at full capacity” in 2022.
In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…
Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…
“This is f***ing corruption, it has to change,” protested an irate John Textor, owner of…
Eduardo Leite, governor of the southern Brazilian state of Rio Grande do Sul, on Wednesday…
Moody’s is the latest rating agency to improve its assessment of Brazil, bumping up the…
Other finalists include the Harvard Business Review, Fortune, Condé Nast, and the NFL